Analgesic efficacy of stellate ganglion block in head and neck cancer pain: A case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 38736790.
- Also identified by DOI 10.4103/jfmpc.jfmpc_1190_23 and PMC identifier 11086807.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with head and neck cancer (HNC) have ongoing pain but Stellate ganglion block which is a sympatholytic block may be a viable therapy for treating it. The data were retrospectively collected from five histopathologically confirmed HNC patients who had completed chemotherapy and radiation doses. Stellate ganglion block was given to these patients and was subsequently monitored for 3 months to assess pain alleviation and overall satisfaction. Over a 3-month period, there was a decrease in the pain levels with a better quality of life so the stellate ganglion block can be a promising modality for reducing the pain of HNC.